济民可信研究院研发科学家在预印本网站bioRxiv发表文章称，正处于临床I期的新冠中和抗体JMB2002注射液对包括南非变异株（B.1.351）在内的多种新冠毒株具有体外阻断活性。文章题目为《A human antibody with blocking activity to RBD proteins of multipleSARS-CoV-2 variants including B.1.351 showed potent prophylactic andtherapeutic efficacy against SARS-CoV-2 in rhesus macaques》。
详情请点击链接查看：https://mp.weixin.qq.com/s/q1Cb1mx2o_76zai6kNexZg
